Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01332825 · ClinicalTrials.gov registry record · NA
cAMP (Cyclic Adenosine Monophosphate) Levels in the Nose
A NA study of Olfactory Disorder, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 41
- Enrollment target
- 1
- Study location
NCT01332825 is a NA study of Olfactory Disorder that has completed, run by University of Washington. The registered enrollment target is 41 participants, below the 96-participant average among 3 other Olfactory Disorder trials with a reported enrollment target (57% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01332825, a NA study of Olfactory Disorder, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine the normal distribution of nasal tissue cathelicidin antimicrobial peptides (cAMP) levels in subjects with normal smell and subjects with smell dysfunction. The investigators will also look at the effect of nasal saline irrigation on olfaction and cAMP levels and if nasal irrigation is capable of harvesting olfactory cilia. The investigators hypothesize that nasal saline will have no effect on olfaction and will be inadequate to harvest olfactory cilia.
Conditions Studied
Interventions
- OTHER saline nasal irrigation
Study Locations (1)
Washington
- University of Washington - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2011-03 |
| Est. Completion | 2012-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01332825
The ClinicalTrials.gov registry entry for NCT01332825 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 96-participant average among 3 other Olfactory Disorder trials with a reported enrollment target (57% lower). The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Olfactory Disorder appearing as the primary indexed condition, and to 1 intervention - of which saline nasal irrigation is the first listed.
NCT01332825 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.
Frequently Asked Questions
What is clinical trial NCT01332825 about?
NCT01332825 is a clinical study titled "cAMP (Cyclic Adenosine Monophosphate) Levels in the Nose". The purpose of this study is to determine the normal distribution of nasal tissue cathelicidin antimicrobial peptides (cAMP) levels in subjects with normal smell and subjects with smell dysfunction. The investigators will also look at the effect of nasal saline irrigation on olfaction and cAMP level...
What is the current status of trial NCT01332825?
This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2011-03. Estimated completion is 2012-12.
What conditions does trial NCT01332825 study?
This clinical trial studies the following conditions: Olfactory Disorder.
What interventions are being tested in trial NCT01332825?
The interventions under investigation include: saline nasal irrigation (OTHER).
Who is sponsoring clinical trial NCT01332825?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01332825 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Olfactory Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.